期刊文献+

慢性肾脏病5期未透析患者血清25羟维生素D3水平及相关因素研究

The study of the serum 25-hydroxyvitamin D3 level and its correlated factors in non-dialysis patients with stage 5 chronic kidney diseases
下载PDF
导出
摘要 目的探讨慢性肾脏病(CKD)5期未透析患者的血清25羟维生素D 3[25(OH)D 3]水平及其相关因素。方法选取在肾内科住院诊断为CKD 5期未透析的72例患者,回顾性的收集患者人口统计学数据及临床资料,根据血清25(OH)D 3水平将患者分为25(OH)D 3缺乏组及非缺乏组,比较两组间临床资料的差异。采用spearman相关分析及逐步多元线性回归分析探讨血清25(OH)D 3水平的相关因素。采用单因素logistic回归分析探讨血清25(OH)D 3缺乏的相关因素,并计算各个相关因素的比值比(OR)及其95%的可信区间(CI)。结果72例CKD 5期未透析患者血清25(OH)D 3水平3.0~38.3μg/L[平均(8.8±7.0)μg/L],25(OH)D 3缺乏组61例,非缺乏组11例,25(OH)D 3缺乏率达到84.7%。25(OH)D 3缺乏组与非缺乏组在血清钙、磷、碱性磷酸酶、全段甲状旁腺激素、氨基末端B型钠尿肽前体、左心室舒张末期内径、左心室后壁厚度、室间隔厚度、左室射血分数的差异无统计学意义(P均>0.05)。Spearman线性相关分析提示:血清25(OH)D 3与血清白蛋白(ρ=0.439)呈正相关(P<0.05),与氨基末端B型钠尿肽前体(ρ=-0.383)、左心室舒张末期内径(ρ=-0.256)呈负相关(P均<0.05);与血清钙、磷、碱性磷酸酶、全段甲状旁腺激素无相关性(P均>0.05)。逐步多元线性回归分析显示血清25(OH)D 3与血清白蛋白呈独立正相关(P<0.05)。单因素logistic回归分析显示仅血清白蛋白<36 g/L(OR=6.058,95%CI:1.206~30.428,P=0.029)可能是血清25(OH)D 3缺乏的危险因素。结论CKD 5期未透析患者的血清25(OH)D 3缺乏可能对CKD 5期未透析患者的心血管疾病有重要影响,而对钙磷代谢的影响比较弱。 Objective To investigate the serum 25-hydroxyvitamin D 3[25(OH)D 3]levels and its correlated factors in non-dialysis patients with stage 5 chronic kidney diseases(CKD).Methods A total of 72 non-dialysis patients with stage 5 CKD were selected.The demographic and clinical data of patients were retrospectively collected.According to the 25(OH)D 3 level,patients were divided into 25(OH)D 3 deficiency group and non-deficiency group.The differences in clinical data between the two groups were compared.Spearman correlation analysis and stepwise multivariate linear regression analysis were used to investigate the correlated factors of serum 25(OH)D 3 levels.Univariate logistic regression analysis was used to investigate the correlation factors of serum 25(OH)D 3 deficiency,calculate the Odds Ratio(OR)and 95%confidence interval(CI).Results The serum 25(OH)D 3 levels in 72 non-dialysis patients with stage 5 CKD were 3.0-38.3(8.8±7.0)μg/L.There were 61 cases in the 25(OH)D 3 deficient group,and 11 cases in the non-deficient group.The deficiency rate of serum 25(OH)D 3 reached to 84.7%.There were no statistically significant difference in serum calcium,phosphorus,alkaline phosphatase,parathyroid hormone,N-terminal pro b-type natriuretic peptide(NT-proBNP),left ventricular end-diastolic diameter(LVIDd),left ventricular posterior wall thickness(LVPWTd),interventricular septum thickness(IVSTd),and left ventricular ejection fraction between the two groups(all P>0.05).Spearman linear correlation analysis showed that serum 25(OH)D 3 was positively correlated with albumin(ρ=0.439,P<0.05),negatively correlated with NT-proBNP(ρ=-0.383)and LVIDd(ρ=-0.256)(all P<0.05).The serum 25(OH)D 3 had no correlation with serum calcium,phosphorus,alkaline phosphatase,and parathyroid hormone(all P>0.05).Stepwise multivariate linear regression analysis showed that serum 25(OH)D 3 had independently positive correlation with serum albumin(P<0.05).Univariate logistic regression analysis showed that serum albumin<36 g/L(OR=6.058,95%CI:1.206-30.428,P=0.029)may be risk factor for 25(OH)D 3 deficiency.Conclusion The serum 25(OH)D 3 deficiency is common in non-dialysis patients with stage 5 chronic kidney disease,which may play an important role in cardiovascular disease,while its effect on calcium and phosphorus metabolism may be weaker.
作者 姜俊 王科 王丽华 王艳 胡志伟 赵宸 兰雷 任伟 Jiang Jun;Wang Ke;Wang Lihua;Wang Yan;Hu Zhiwei;Zhao Chen;Lan Lei;Ren Wei(Department of Nephrology,South District of the First Affiliated Hospital of University of Science and Technology of China,Hefei 230036,China)
出处 《中国临床保健杂志》 CAS 2020年第1期109-114,共6页 Chinese Journal of Clinical Healthcare
关键词 肾病 骨化三醇 危险因素 Nephrosis Calcitriol Risk factors
  • 相关文献

参考文献3

二级参考文献46

  • 1<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 2K/DOQI cllnical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis, 2003, 42: S1-S201.
  • 3Holick MF. Vitamin D deficiency. N Engl J Med, 2007, 357: 266-281.
  • 4Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney lnt, 2007, 71: 134-139.
  • 5Gonzalez EA, Sachdeva A, Oliver DA, et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol, 2004, 24: 503-510.
  • 6Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int, 2007, 71: 31-38.
  • 7Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med, 1998, 338: 777-783.
  • 8Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol, 1994, 41: 290-296.
  • 9Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(0H) vitamin D3. Cell, 1999, 96: 507-515.
  • 10Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25- hydroxyvitamin D levels and risk of incident hypertension. Hypertension, 2007, 49: 1063-1069.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部